KRMD KORU Medical Net Sales Margin

Public company logo of KORU Medical (KRMD)

KORU Medical Systems (KRMD) current net profit margin demonstrates profitability dynamics, where the current value equals -1.80. Revenue growth is based on the sale of consumables for home infusions, which create a recurring payment stream. Stability is ensured by dominance in the subcutaneous immunoglobulin administration segment. High barriers to entry are maintained by patents and FDA certification, which prevents patients from switching to other medical systems.

KORU Medical Systems, Inc. (KRMD) Net Return on Sales: for the period 07/04/2022 - 11/19/2026

Summary analytical data breakdowns for KORU Medical (KRMD)

- market value and analyst target forecast:
Initial company analysis:KORU Medical Systems
Manufactured product of korumedical.com

The aggressive expansion of KORU Medical Systems and the scaling of Freedom pump sales require strict control of operating expenses to ensure profitability. An analysis of net profit margin reveals hidden cost growth alongside increasing revenue, demonstrating the actual share of bottom-line profit in every dollar of sales and confirming the fundamental capital stability of the issuer.

Analysis of competing companies

Intuitive Surgical, Inc. (ISRG) - Net Margin|Net Margin Danaher Corporation (DHR)|Net Margin Becton Dickinson & Co|Net Return on Sales STE (STERIS plc)|Return on Sales by Net Profit WST (West Pharmaceutical Services Inc)|Company Net Profitability BAX|Masimo Corporation - Return on Sales by Net Profit|Company Net Profitability STVN (Stevanato Group SpA)|TFX: Return on Sales by Net Profit|Company Sales Margin Merit Medical Corp MMSI|NVST: Net Sales Margin|ICUI - Company Sales Margin|XRAY (Sirona Dental Systems) - Net Sales Margin|Net Margin LeMaitre Vascular Inc LMAT|Net Margin AtriCure Corp (ATRC)|Net Sales Margin STAAR Surgical Corp (STAA)|Net Margin niagenbioscience.com NAGE|ZimVie Inc. - Net Margin|ANGO - Net Margin|Company Sales Margin Cerus Corp CERS|TKNO (Alpha Teknova Inc) - Return on Sales by Net Profit|Monogram Technologies Inc - Net Profit Rate|Return on Sales by Net Profit STSS|InfuSystem Holdings, Inc. (INFU) - Company Sales Margin|Net Sales Margin UTMD|Company Sales Margin Nyxoah, S.A.|Microbot Medical Inc - Return on Sales by Net Profit|Company Sales Margin Pro-Dex Inc. (PDEX)|Zentek - Net Sales Margin|Elutia (ELUT) - Return on Sales by Net Profit|Milestone Scientific Inc (MLSS) - Net Margin|NXGL - Company Sales Margin|Return on Sales by Net Profit RVP|Harvard Bioscience, Inc. (HBIO) - Company Sales Margin|Net Sales Margin FEMY|Net Sales Margin Meihua Medical Technologies (MHUA)|Net Sales Margin POAI (Predictive Oncology)|CJMB - Return on Sales by Net Profit|ATRI: Return on Sales by Net Profit|NeuroMetrix, Inc. (NURO) - Return on Sales by Net Profit